Results 241 to 250 of about 309,043 (332)
Correction: Transarterial embolization for acute lower gastrointestinal bleeding: a retrospective bicentric study. [PDF]
Tiralongo F +14 more
europepmc +1 more source
Aims To evaluate the effects of vepdegestrant, a PROteolysis TArgeting Chimera (PROTAC) oestrogen receptor degrader, on the pharmacokinetics of dabigatran (a P‐glycoprotein [P‐gp] substrate) and rosuvastatin (a breast cancer resistance protein [BCRP] substrate).
Derek Z. Yang +9 more
wiley +1 more source
Chronic Pancreatitis Complicated by Pseudoaneurysm Causing Gastrointestinal Bleeding. [PDF]
Boeur BY, Haidari H, Kumar S.
europepmc +1 more source
Introduction Bevacizumab, a vascular endothelial growth factor inhibitor, is used off‐label for treatment of severe anaemia related to epistaxis, gastrointestinal bleeding and/or severe hepatic arteriovenous malformations (HAVM) and right‐sided cardiac failure in patients with hereditary haemorrhagic telangiectasia (HHT).
Pernille D. Haahr +18 more
wiley +1 more source
Correlation analysis between frequency of gastrointestinal bleeding episodes and abnormal coagulation indexes in digestive system tumors. [PDF]
Shaoqing A, Jun G, Jia W, Jie L.
europepmc +1 more source
Fostamatinib and the risk of acute aortic dissection in immune thrombocytopenia
Immune thrombocytopenia (ITP) is a rare autoimmune disorder characterized by platelet destruction. While most patients respond to first‐ or second‐line therapies, a small subset is multirefractory. Fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, is a therapeutic option in these cases.
Paul Dalmas +7 more
wiley +1 more source

